Genetic Counseling Clinical Trial
— GC3ModesOfficial title:
Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital
Verified date | July 2021 |
Source | University of California, San Francisco |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Using mixed methods, investigators will conduct a multicenter partially randomized preference noninferiority trial with high-risk English-, Spanish-, and Cantonese-speaking patients assigned by (1) patients´ preference or (2) randomization to three counseling modes: (a) in-person; (b) phone; or (c) video conference. A total of 600 patients will complete counseling and 540 will complete the final survey. Baseline and post-counseling surveys will use validated measures (adapted for literacy and language) of study outcomes. All counseling sessions will be audio-taped. A sample of 90 tapes will be analyzed for counseling content and to identify 30 participants for in-depth interviews and analysis triangulating all forms of data. Genetic counselors will be interviewed in depth to elicit their perceptions of the strengths and limitations of each counseling mode.
Status | Completed |
Enrollment | 1273 |
Est. completion date | December 16, 2019 |
Est. primary completion date | December 16, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria:Eligible participants include patients who - visit the mammography, high risk or oncology clinics at Contra Costa County, Highland or SFGH hospitals, - are referred to genetic counseling services at SFGH by a community clinic through the E-Referral system or are considered to be high risk based on their breast/ovarian cancer genetics Referral Screening Tool (RST) score (= 2 checks) - speak English, Spanish, or Cantonese Investigators will also include two genetic counselors who provide services at SFGH and UCSF. Exclusion Criteria: - do not speak English, Spanish, or Cantonese; - are age 17 and under; and - don't have a family history of cancer. |
Country | Name | City | State |
---|---|---|---|
United States | Contra Costa Regional Medical Center Health Services | Martinez | California |
United States | Highland General Hospital | Oakland | California |
United States | San Francisco General Hospital | San Francisco | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Francisco | National Cancer Institute (NCI), National Institutes of Health (NIH), University of California, Davis |
United States,
Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA. 2005 Apr 13;293(14):1729-36. — View Citation
Cohen SA, Marvin ML, Riley BD, Vig HS, Rousseau JA, Gustafson SL. Identification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task Force. J Genet Couns. 2013 Aug;22(4):411-21. doi: 10.1007/s10897-013-9588-0. Epub 2013 Apr 25. — View Citation
D'Agostino RB Sr, Massaro JM, Sullivan LM. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics. Stat Med. 2003 Jan 30;22(2):169-86. — View Citation
Forman AD, Hall MJ. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer. Breast J. 2009 Sep-Oct;15 Suppl 1:S56-62. doi: 10.1111/j.1524-4741.2009.00798.x. Review. — View Citation
Green LW, Glasgow RE. Evaluating the relevance, generalization, and applicability of research: issues in external validation and translation methodology. Eval Health Prof. 2006 Mar;29(1):126-53. Review. — View Citation
Halbert CH, Kessler L, Stopfer JE, Domchek S, Wileyto EP. Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer. Genet Med. 2006 Sep;8(9):576-82. — View Citation
Hall MJ, Olopade OI. Disparities in genetic testing: thinking outside the BRCA box. J Clin Oncol. 2006 May 10;24(14):2197-203. Review. — View Citation
Joseph G, Guerra C. To worry or not to worry: breast cancer genetic counseling communication with low-income Latina immigrants. J Community Genet. 2015 Jan;6(1):63-76. doi: 10.1007/s12687-014-0202-4. Epub 2014 Aug 23. — View Citation
Karliner LS, Napoles-Springer A, Kerlikowske K, Haas JS, Gregorich SE, Kaplan CP. Missed opportunities: family history and behavioral risk factors in breast cancer risk assessment among a multiethnic group of women. J Gen Intern Med. 2007 Mar;22(3):308-14. — View Citation
King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003 Oct 24;302(5645):643-6. — View Citation
Kinney AY, Butler KM, Schwartz MD, Mandelblatt JS, Boucher KM, Pappas LM, Gammon A, Kohlmann W, Edwards SL, Stroup AM, Buys SS, Flores KG, Campo RA. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. J Natl Cancer Inst. 2014 Nov 5;106(12). pii: dju328. doi: 10.1093/jnci/dju328. Print 2014 Dec. — View Citation
Lea DH, Kaphingst KA, Bowen D, Lipkus I, Hadley DW. Communicating genetic and genomic information: health literacy and numeracy considerations. Public Health Genomics. 2011;14(4-5):279-89. doi: 10.1159/000294191. Epub 2010 Apr 20. — View Citation
Madlensky L. Is it time to embrace telephone genetic counseling in the oncology setting? J Clin Oncol. 2014 Mar 1;32(7):611-2. doi: 10.1200/JCO.2013.53.8975. Epub 2014 Jan 21. — View Citation
Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer. 2004 Sep;4(9):665-76. Review. — View Citation
Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2014 Feb 18;160(4):255-66. Review. — View Citation
Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer. 2000 Nov;83(10):1301-8. — View Citation
Schwartz MD, Valdimarsdottir HB, Peshkin BN, Mandelblatt J, Nusbaum R, Huang AT, Chang Y, Graves K, Isaacs C, Wood M, McKinnon W, Garber J, McCormick S, Kinney AY, Luta G, Kelleher S, Leventhal KG, Vegella P, Tong A, King L. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol. 2014 Mar 1;32(7):618-26. doi: 10.1200/JCO.2013.51.3226. Epub 2014 Jan 21. — View Citation
Squiers L, Peinado S, Berkman N, Boudewyns V, McCormack L. The health literacy skills framework. J Health Commun. 2012;17 Suppl 3:30-54. doi: 10.1080/10810730.2012.713442. — View Citation
Sussner KM, Jandorf L, Thompson HS, Valdimarsdottir HB. Interest and beliefs about BRCA genetic counseling among at-risk Latinas in New York City. J Genet Couns. 2010 Jun;19(3):255-68. doi: 10.1007/s10897-010-9282-4. Epub 2010 Feb 12. — View Citation
Vig HS, Wang C. The evolution of personalized cancer genetic counseling in the era of personalized medicine. Fam Cancer. 2012 Sep;11(3):539-44. doi: 10.1007/s10689-012-9524-8. — View Citation
Whittemore AS, Gong G, John EM, McGuire V, Li FP, Ostrow KL, Dicioccio R, Felberg A, West DW. Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2078-83. — View Citation
* Note: There are 21 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Differences in change scores among three counseling modes: Breast Cancer Knowledge Scale | Will measure knowledge of hereditary breast cancer information before and after delivery of counseling modes. | One week post counseling | |
Primary | Differences in change scores among three counseling modes: Impact of Events Scale | Will measure cancer-specific distress before and after delivery of counseling modes. | One week post counseling | |
Secondary | Differences in change scores among three counseling modes: Decisional Conflict Scale | Will measure decisional conflict before and after implementation of counseling modes. | One week post counseling | |
Secondary | Differences in change scores among three counseling modes: Perceived Stress Scale | Will measure general perceptions of stress before and after implementation of counseling modes. | One week post counseling | |
Secondary | Differences in change scores among three counseling modes: Breast/Ovarian Cancer Risk Perception and Worry Scale | Will measure breast cancer and ovarian cancer risk perception and worry before and after implementation of counseling modes. | One week post counseling | |
Secondary | Differences in change scores among three counseling modes: Perceptions of Risks and Benefits of Genetic Counseling Scale | Will measure perceptions of risks and benefits of genetic counseling before and after implementation of counseling modes. | One week post counseling | |
Secondary | Differences in change scores among three counseling modes: Genetic Counseling Satisfaction Scale | Will measure genetic counseling satisfaction before and after implementation of counseling modes. | One week post counseling |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02586428 -
Noninvasive Prenatal Testing
|
N/A | |
Completed |
NCT00047905 -
Pilot Study of the Process of Prenatal Genetic Counseling
|
N/A | |
Completed |
NCT04119349 -
Influence of Prenatal Counseling in Invasive Testing
|
N/A | |
Active, not recruiting |
NCT04428710 -
Assessment Psychological Distress for Cancer Heredity Test
|
||
Recruiting |
NCT05360095 -
Comparing Game Facilitated Interactivity to Genetic Counseling for Prenatal Screening Education
|
N/A | |
Completed |
NCT03024424 -
Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD
|
N/A | |
Completed |
NCT00360711 -
Genetic Counselors' Experiences of Moral Value Conflicts With Clients
|
N/A | |
Completed |
NCT04575350 -
Reinterpretation of CNV With Unknown Significance: a 5-year Retrospective Analysis
|
||
Enrolling by invitation |
NCT05422573 -
Clinical Trial of the Sequence of Cardiovascular Genetic Counseling and Testing
|
N/A | |
Completed |
NCT05805982 -
Educational Video Versus In-person Genetic Counseling for Hereditary Cancer
|
N/A | |
Completed |
NCT00057694 -
The Value of Genetic Information to Adult Adopted Individuals
|
N/A |